The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Immunome Inc (NASDAQ: IMNM) closed at $7.46 down -3.24% from its previous closing price of $7.71. In other words, the price has decreased by -$3.24 from its previous closing price. On the day, 0.81 million shares were traded.
Ratios:
For a deeper understanding of Immunome Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.08. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on April 02, 2025, initiated with a Buy rating and assigned the stock a target price of $23.
On November 08, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $27 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 25 ’25 when BIENAIME JEAN JACQUES bought 7,800 shares for $7.78 per share. The transaction valued at 60,684 led to the insider holds 31,415 shares of the business.
SIEGALL CLAY B bought 137,100 shares of IMNM for $999,459 on Mar 26 ’25. The President and CEO now owns 806,736 shares after completing the transaction at $7.29 per share. On Mar 24 ’25, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, bought 7,000 shares for $8.21 each. As a result, the insider paid 57,470 and bolstered with 23,615 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 71.80 while its Price-to-Book (P/B) ratio in mrq is 2.65.
Stock Price History:
Over the past 52 weeks, IMNM has reached a high of $16.81, while it has fallen to a 52-week low of $5.15. The 50-Day Moving Average of the stock is -5.70%, while the 200-Day Moving Average is calculated to be -33.94%.
Shares Statistics:
A total of 87.01M shares are outstanding, with a floating share count of 76.85M. Insiders hold about 11.68% of the company’s shares, while institutions hold 69.48% stake in the company.
